OncoLogics, JointGlow to Offer Non-Surgical Joint Pain Treatment in Acadiana

LAFAYETTE, LA — August 1, 2026 — OncoLogics, a premier provider of advanced cancer care across the Acadiana region, today announced a new collaboration with JointGlow to offer low-dose radiotherapy (LDRT) to patients suffering from chronic musculoskeletal pain, osteoarthritis and inflammatory tissue disorders. LDRT is an FDA-cleared, highly effective, non-invasive joint pain treatment option offering patients long-term relief without surgery or steroids.

Through this innovative collaboration, OncoLogics will deliver the proprietary JointGlow LDRT protocol with its state-of-the-art linear accelerators and radiotherapy equipment.

The treatment experience is painless, non-invasive, and seamless. Using ultra-low doses of energy, LDRT targets the joint at the cellular level, prompting overactive, pro-inflammatory immune cells to switch to an anti-inflammatory “repair” state.

The efficacy of LDRT is supported by substantial data. Peer-reviewed clinical studies show high success rates for difficult-to-treat areas, such as knee osteoarthritis and chronic plantar fasciitis.

By applying established radiotherapy frameworks to benign musculoskeletal conditions, OncoLogics is extending its reach to more patients in Acadiana.

“We know that many patients are frustrated by chronic joint pain and are searching for alternatives to surgery or ongoing injections,” said Dr. Jonathan Thompson, Certified Physician in Low Dose Radiotherapy at OncoLogics. “Collaborating with JointGlow allows us to offer a treatment that fits naturally into our care model and provides another option for people who want relief without an invasive procedure. We’re excited to make this available to the communities we serve.”

“Living with chronic joint pain can affect just about every part of a person’s daily life,” said JointGlow Founder and CEO Gokul Solai, MD. “We’re pleased to collaborate with OncoLogicsto give patients a treatment option that addresses underlying inflammation and produces results that can last longer than traditional approaches.”

To schedule a consultation, visit https://oncologics.net/contact-us/.